Literature DB >> 8730475

A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?

G Bordin1, M Ballaré, P Zigrossi, M C Bertoncelli, L Paccagnino, A Baroli, M Brambilla, A Monteverde, E Inglese.   

Abstract

OBJECTIVE: In order to investigate HCV associated thrombocytopenia, 6 patients suffering from this disease, in the absence of splenomegaly and other common causes of peripheral platelet destruction, underwent laboratory and scintigraphic tests.
RESULTS: Thrombokinetic studies revealed a significant, nearly linear, delayed splenic accumulation with normal or low-normal values for the average platelet life span, low-normal recovery, and depressed platelet production. Megakariopoiesis was normal or slightly increased. HCV infection of the megakariocytes was found in two patients. Autoantibodies and liver disease were also investigated.
CONCLUSIONS: A role of immunological mechanisms in HCV associated thrombocytopenia appears to be ruled out. The authors conclude that tests for HCV infection should be included in the evaluation of thrombocytopenia in adults and a possible direct involvement of HCV cannot be excluded.

Entities:  

Mesh:

Year:  1995        PMID: 8730475

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

Review 1.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

2.  Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.

Authors:  Elizabeth Y Chiao; Eric A Engels; Jennifer R Kramer; Kenneth Pietz; Louise Henderson; Thomas P Giordano; Ola Landgren
Journal:  Arch Intern Med       Date:  2009-02-23

3.  Role of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahemd E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2008-07       Impact factor: 2.485

4.  Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis.

Authors:  Paola Mancino; Katia Falasca; Claudio Ucciferri; Eligio Pizzigallo; Jacopo Vecchiet
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-03-31       Impact factor: 2.576

5.  Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts.

Authors:  Kung-Hung Lin; Ping-I Hsu; Hsien-Chung Yu; Chun-Ku Lin; Wei-Lun Tsai; Wen-Chi Chen; Hoi-Hung Chan; Kwok-Hung Lai
Journal:  BMC Gastroenterol       Date:  2012-01-18       Impact factor: 3.067

6.  Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.

Authors:  Xianghua Zeng; Cheng Xu; Dengming He; Maoshi Li; Huiyan Zhang; Quanxin Wu; Dedong Xiang; Yuming Wang
Journal:  Croat Med J       Date:  2015-06       Impact factor: 1.351

7.  Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.

Authors:  Connie L Erickson-Miller; Evelyne Delorme; Shin-Shay Tian; Christopher B Hopson; Amy J Landis; Elizabeth I Valoret; Teresa S Sellers; Jon Rosen; Stephen G Miller; Juan I Luengo; Kevin J Duffy; Julian M Jenkins
Journal:  Stem Cells       Date:  2009-02       Impact factor: 6.277

Review 8.  Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag.

Authors:  Fazal A Danish; Salman S Koul; Fazal R Subhani; Ahmed E Rabbani; Saeeda Yasmin
Journal:  Saudi J Gastroenterol       Date:  2010 Jan-Mar       Impact factor: 2.485

Review 9.  Pathobiology of secondary immune thrombocytopenia.

Authors:  Douglas B Cines; Howard Liebman; Roberto Stasi
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

Review 10.  Human platelets and their capacity of binding viruses: meaning and challenges?

Authors:  Adrien Chabert; Hind Hamzeh-Cognasse; Bruno Pozzetto; Fabrice Cognasse; Mirta Schattner; Ricardo M Gomez; Olivier Garraud
Journal:  BMC Immunol       Date:  2015-04-28       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.